© 2022 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
Dermatologist and professor Brad Glick, DO, FAAD, leads a monthly conversation with a fellow expert on the trends, news, and musings from the medical field of dermatology.
April 20, 2022
Dr. Brett King returns to discuss the impact of JAK inhibitors in the management of atopic dermatitis.
December 21, 2021
Dr. Moody speaks to how these E/M code changes affect billing documentation and patient care.
September 15, 2021
In this episode of Derm Discussions, vitiligo expert John Harris, MD, PhD, discusses new tactics and therapeutic options in treating inflammatory skin disorders like vitiligo, alopecia areata, and atopic dermatitis.
July 26, 2021
On the latest Derm Discussions, Brett King, MD, PhD, joins Brad Glick, DO, to discuss the potential of the JAK inhibitor class for dermatology.
May 30, 2021
Misha Rosenbach, MD, discusses how rising temperatures and climate change, issues of public health concern, are relevant to the field of dermatology.
April 23, 2021
Rebecca Kazin, MD, offers some insight into her cosmetic dermatology practices, including a new hair product that she developed.
March 07, 2021
Valerie Callender, MD, draws on her experiences in clinical practice to discuss cosmetic dermatology care practices and the challenges of this past year.
January 31, 2021
Todd Schlesinger, MD, talks new therapies on the horizon and those that have already proven efficacious.
December 21, 2020
In this episode of Derm Discussions, Peter Lio, MD, discusses the difficulties treating itch as well as alternative—and perhaps surprising—therapeutic options.
November 10, 2020
Lisa Swanson, MD, and Brad Glick, DO, FAAD, discuss a wide range of dermatological conditions faced by pediatric patients—from acne to atopic dermatitis, and everything in between.
New AHA Statement Highlights Symptom Relevance in Cardiovascular Disease
Human Adenovirus Prominently Found in Children With Acute Hepatitis
Phase 1/2 Trial Reports Positive Initial Clinical Data of VRDN-001 in Thyroid Eye Disease